DNMT aberration-incurred GPX4 suppression prompts osteoblast ferroptosis and osteoporosisBinjia Ruan, Yongxiang Wang, Jian Dong et al.|Bone Research|2024Cited by 47
U.S. Food and Drug Administration Approval Summary: Enzalutamide for the Treatment of Patients With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate CancerYang‐Min Ning, Richard Pazdur, Geoffrey Kim et al.|The Oncologist|2015Cited by 42
DNMT aberration-incurred GPX4 suppression prompts osteoblast ferroptosis and osteoporosisYongxiang Wang, Hui Dong, Chulin Li et al.|Research Square|2024Cited by 1